日本ケミファ(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証STD | 医薬品 | 4539/E00957 | NIPPON CHEMIPHAR CO., LTD. |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2023/11/17 | 日証協 | 47,293株 | +7.01% | 18,916株 | -11.23% | 60,452株 | +3.47% | 4,001株 | -47.15% |
2023/11/10 | 日証協 | 44,193株 | +11.06% | 21,308株 | +1830.07% | 58,423株 | +7.29% | 7,571株 | +122.48% |
2023/11/02 | 日証協 | 39,793株 | -15.14% | 1,104株 | -94.01% | 54,452株 | -8.51% | 3,403株 | -58.35% |
2023/10/27 | 日証協 | 46,893株 | +15.81% | 18,416株 | -9.74% | 59,520株 | +9.52% | 8,171株 | +13.47% |
2023/10/20 | 日証協 | 40,493株 | -5.81% | 20,404株 | +208.78% | 54,348株 | -4.06% | 7,201株 | +118.21% |
2023/10/13 | 日証協 | 42,993株 | -14.42% | 6,608株 | -4.87% | 56,648株 | -11.28% | 3,300株 | +141.23% |
2023/10/06 | 日証協 | 50,240株 | -8.95% | 6,946株 | -19% | 63,848株 | +25.42% | 1,368株 | -94.87% |
2023/09/29 | 日証協 | 55,176株 | +0.36% | 8,575株 | +71.53% | 50,906株 | -33.06% | 26,646株 | +886.89% |
2023/09/22 | 日証協 | 54,976株 | +1.1% | 4,999株 | -32.78% | 76,046株 | +1.33% | 2,700株 | -57.15% |
2023/09/15 | 日証協 | 54,376株 | +1.3% | 7,437株 | +907.72% | 75,046株 | +6.98% | 6,301株 | +119.47% |
2023/09/08 | 日証協 | 53,676株 | -1.52% | 738株 | -77.44% | 70,150株 | -0.99% | 2,871株 | -13% |
2023/09/01 | 日証協 | 54,505株 | -0.73% | 3,272株 | -60.48% | 70,850株 | -4.84% | 3,300株 | -15.45% |
2023/08/25 | 日証協 | 54,905株 | -1.67% | 8,279株 | -4.27% | 74,457株 | +4.63% | 3,903株 | -80.19% |
2023/08/18 | 日証協 | 55,838株 | +0.6% | 8,648株 | +25.04% | 71,162株 | +0.57% | 19,705株 | -9.19% |
2023/08/10 | 日証協 | 55,505株 | +0.6% | 6,916株 | +0.16% | 70,758株 | +2.12% | 21,700株 | -23.24% |
2023/08/04 | 日証協 | 55,176株 | +2.04% | 6,905株 | +1992.42% | 69,288株 | +0.59% | 28,270株 | -0.43% |
2023/07/28 | 日証協 | 54,072株 | -4.08% | 330株 | -79.38% | 68,883株 | -2.96% | 28,392株 | +62.07% |
2023/07/21 | 日証協 | 56,372株 | -2.76% | 1,600株 | -91.93% | 70,985株 | -6.75% | 17,518株 | +26.98% |
2023/07/14 | 日証協 | 57,972株 | -1.48% | 19,828株 | +3052.31% | 76,124株 | +2.28% | 13,796株 | +17.91% |
※株式分割は考慮していませんのでご注意ください。